AstraZeneca Plc has announced plans to expand its respiratory franchise by in-licensing rights to a group of marketed and investigational products for asthma and chronic obstructive pulmonary disease (COPD) from Almirall SA of Spain. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
